The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Skopets I.S.

Petrozavodsk State University, Petrozavodsk, Russia

Vezikova N.N.

Petrozavodskiĭ gosudarstvennyĭ universitet

Ivanova E.P.

FPDO GBOU VPO "Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet" Minzdravsotsrazvitiia Rossii

Sergeeva S.S.

V.A. Baranov Republican Hospital, Petrozavodsk, Russia

Ignatenko O.V.

Department of Intermediate-Level Surgery and Urology, Therapeutic Faculty, N.I. Pirogov Russian National Research Medical University, Moscow, Russia, N.I. Pirogov City Clinical Hospital No 1, Moscow, Russia

A case of irreversible cardiomyopathy induced by polychemotherapy

Authors:

Skopets I.S., Vezikova N.N., Ivanova E.P., Sergeeva S.S., Ignatenko O.V.

More about the authors

Journal: Therapeutic Archive. 2015;87(12): 73‑76

Read: 1626 times


To cite this article:

Skopets IS, Vezikova NN, Ivanova EP, Sergeeva SS, Ignatenko OV. A case of irreversible cardiomyopathy induced by polychemotherapy. Therapeutic Archive. 2015;87(12):73‑76. (In Russ.)
https://doi.org/10.17116/terarkh2015871273-76

References:

  1. Bedritskii S.A., Larionova V.B., Snegovoi A.V. Klinicheskie rekomendatsii po kardiovaskulyarnoi toksichnosti indutsirovannoi khimioterapiei i targetnymi preparatami. Dostupno po: http://oncology-association.ru/docs/recomend/ 60kardiovaskulyarnoy-toksichnosti-dec2014.pdf
  2. Korneeva O.N., Drapkina O.M., Kozlova E.V., Ivashkin V.T. Kardiomiopatiya, indutsirovannaya polikhimioterapiei, u bol'noi rakom molochnoi zhelezy. Klinitsist. 2011;5(3):109-111. doi:10.17650/1818-8338-2011-3-109-111.
  3. Semenova A.I. Kardio- i neirotoksichnost' protivoopukholevykh preparatov (patogenez, klinika, profilaktika, lechenie). Prakticheskayaonkologiya. 2009;3(10):168-176.
  4. Avchukhova L.S., Salamatina L.V., Urvantseva I.A., Kudryavtseva O.V., Rudenko A.V., Morgunov D.P. Kardiomiopatiya, indutsirovannaya tartuzumabom. Kardiologiya. 2014;1:92-94.
  5. Moiseev V.S., Kiyakbaev G.K. Kardiomiopatii i miokardity. M.: GEOTAR-Media; 2012.
  6. Shuikova K.V., Shmelina E.I., Gendlin G.E., Storozhakov G.I. Kardiotoksichnost' sovremennykh khimioterapevticheskikh preparatov. Atmosfera. Novosti kardiologii. 2012;3: 9-19.
  7. Baron KB, Brown JR, Heiss BL, Marshall J, Tait N, Tkaczuk KH, Gottlieb SS. Trastuzumab-induced cardiomyopathy: incidence and associated risk factors in an inner-city population. J Card Fail. 2014;20(8):555-559.
  8. Groarke J, Tong D, Khambhati J, Cheng S, Moslehi J. Breast cancer therapies and cardiomyopathy. Med Clin North Am. 2012;96(5):1001-1019.
  9. Wang SY, Long JB, Hurria A, Owusu C, Steingart RM, Gross CP, Chen J. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival. Breast Cancer Res Treat. 2014;146(2):411-419.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.